Edit |   |
Antigenic Specificity | p42 MAPK (erk2) |
Clone | polyclonal |
Host Species | Rabbit |
Reactive Species | human, mouse, rat |
Isotype | n/a |
Format | affinity purified |
Size | 0.1 mL |
Concentration | n/a |
Applications | Western Blot (WB), Immunohistochemistry (IHC) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Mitogen-activated protein kinases (MAPKs) are a widely conserved family of serine/threonine protein kinases involved in many cellular programs such as cell proliferation, differentiation, motility, and death. The p44/42 MAPK (Erk1/2) signaling pathway can be activated in response to a diverse range of extracellular stimuli including mitogens, growth factors, and cytokines (1-3) and is an important target in the diagnosis and treatment of cancer (4). Upon stimulation, a sequential three-part protein kinase cascade is initiated, consisting of a MAP kinase kinase kinase (MAPKKK or MAP3K), a MAP kinase kinase (MAPKK or MAP2K), and a MAP kinase (MAPK). Multiple p44/42 MAP3Ks have been identified, including members of the Raf family, as well as M |
Immunogen | Immunogen: N term-peptide of human MAPK1 Storage Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3. |
Other Names | [MAPK1; ERK; ERK2; ERT1; MAPK2; P42MAPK; PRKM1; PRKM2; p38; p40; p41; p41mapk] |
Gene, Accession # | [p42 MAPK], Gene ID: 5594, NCBI: NP_002736.3, UniProt: P28482 |
Catalog # | MBS8504847 |
Price | $310 |
Order / More Info | p42 MAPK (erk2) Antibody from MYBIOSOURCE INC. |
Product Specific References | 1. Roux, P.P. and Blenis, J. (2004) Microbiol Mol Biol Rev 68, 320-44. 2. Baccarini, M. (2005) FEBS Lett 579, 3271-7. 3. Meloche, S. and Pouyssegur, J. (2007) Oncogene 26, 3227-39. 4. Roberts, P.J. and Der, C.J. (2007) Oncogene 26, 3291-310. 5. Rubinfeld, H. and Seger, R. (2005) Mol Biotechnol 31, 151-74. 6. Murphy, L.O. and Blenis, J. (2006) Trends Biochem Sci 31, 268-75. 7. Dalby, K.N. et al. (1998) J Biol Chem 273, 1496-505. 8. Marais, R. et al. (1993) Cell 73, 381-93. 9. Kortenjann, M. et al. (1994) Mol Cell Biol 14, 4815-24. 10. Owens, D.M. and Keyse, S.M. (2007) Oncogene 26, 3203-13. |